59 related articles for article (PubMed ID: 15942653)
1. Utilizing a GnRH-based chimeric protein for the detection of adenocarcinoma.
Lichtenstein M; Ben-Yehudah A; Belostotsky R; Eaveri R; Sabag O; Grodzovski I; Lorberboum-Galski H
Int J Oncol; 2005 Jul; 27(1):143-8. PubMed ID: 15942653
[TBL] [Abstract][Full Text] [Related]
2. Using apoptosis for targeted cancer therapy by a new gonadotropin releasing hormone-DNA fragmentation factor 40 chimeric protein.
Ben-Yehudah A; Aqeilan R; Robashkevich D; Lorberboum-Galski H
Clin Cancer Res; 2003 Mar; 9(3):1179-90. PubMed ID: 12631624
[TBL] [Abstract][Full Text] [Related]
3. Targeted cancer therapy with gonadotropin-releasing hormone chimeric proteins.
Ben-Yehudah A; Lorberboum-Galski H
Expert Rev Anticancer Ther; 2004 Feb; 4(1):151-61. PubMed ID: 14748665
[TBL] [Abstract][Full Text] [Related]
4. Surface antigens/receptors for targeted cancer treatment: the GnRH receptor/binding site for targeted adenocarcinoma therapy.
Eaveri R; Ben-Yehudah A; Lorberboum-Galski H
Curr Cancer Drug Targets; 2004 Dec; 4(8):673-87. PubMed ID: 15578922
[TBL] [Abstract][Full Text] [Related]
5. GnRH-Bik/Bax/Bak chimeric proteins target and kill adenocarcinoma cells; the general use of pro-apoptotic proteins of the Bcl-2 family as novel killing components of targeting chimeric proteins.
Azar Y; Lorberboum-Galski H
Apoptosis; 2000 Dec; 5(6):531-42. PubMed ID: 11303912
[TBL] [Abstract][Full Text] [Related]
6. Utilizing chimeric proteins for exploring the cellular fate of endogenous proteins.
Ben-Yehudah A; Aqeilan R; Belostotsky R; Azar Y; Lorberboum-Galski H
Biochem Biophys Res Commun; 2002 Jan; 290(1):332-8. PubMed ID: 11779174
[TBL] [Abstract][Full Text] [Related]
7. Development of novel 68Ga- and 18F-labeled GnRH-I analogues with high GnRHR-targeting efficiency.
Schottelius M; Berger S; Poethko T; Schwaiger M; Wester HJ
Bioconjug Chem; 2008 Jun; 19(6):1256-68. PubMed ID: 18510351
[TBL] [Abstract][Full Text] [Related]
8. Cloning, expression, and purification of a highly immunogenic recombinant gonadotropin-releasing hormone (GnRH) chimeric peptide.
Xu J; Zhu Z; Duan P; Li W; Zhang Y; Wu J; Hu Z; Roque RS; Liu J
Protein Expr Purif; 2006 Dec; 50(2):163-70. PubMed ID: 17064933
[TBL] [Abstract][Full Text] [Related]
9. Gonadotropin releasing hormone analogs induce apoptosis by extrinsic pathway involving p53 phosphorylation in primary cell cultures of human prostatic adenocarcinomas.
Clementi M; Sánchez C; Benitez DA; Contreras HR; Huidobro C; Cabezas J; Acevedo C; Castellón EA
Prostate; 2009 Jul; 69(10):1025-33. PubMed ID: 19301301
[TBL] [Abstract][Full Text] [Related]
10. Genetic engineering, expression, and activity of a chimeric monoclonal antibody-avidin fusion protein for receptor-mediated delivery of biotinylated drugs in humans.
Boado RJ; Zhang Y; Zhang Y; Xia CF; Wang Y; Pardridge WM
Bioconjug Chem; 2008 Mar; 19(3):731-9. PubMed ID: 18278853
[TBL] [Abstract][Full Text] [Related]
11. Targeted induction of apoptosis by chimeric granzyme B fusion proteins carrying antibody and growth factor domains for cell recognition.
Dälken B; Giesübel U; Knauer SK; Wels WS
Cell Death Differ; 2006 Apr; 13(4):576-85. PubMed ID: 16179940
[TBL] [Abstract][Full Text] [Related]
12. Gonadotropin-releasing hormone type II antagonists induce apoptotic cell death in human endometrial and ovarian cancer cells in vitro and in vivo.
Fister S; Günthert AR; Emons G; Gründker C
Cancer Res; 2007 Feb; 67(4):1750-6. PubMed ID: 17308117
[TBL] [Abstract][Full Text] [Related]
13. Specific GATA-binding elements in the GnRH promoter are required for gene expression pulse activity: role of GATA-4 and GATA-5 in this intermittent process.
Leclerc GM; Bose SK; Boockfor FR
Neuroendocrinology; 2008; 88(1):1-16. PubMed ID: 18259093
[TBL] [Abstract][Full Text] [Related]
14. Gonadotropin-releasing hormone type II induces apoptosis of human endometrial cancer cells by activating GADD45alpha.
Wu HM; Cheng JC; Wang HS; Huang HY; MacCalman CD; Leung PC
Cancer Res; 2009 May; 69(10):4202-8. PubMed ID: 19366794
[TBL] [Abstract][Full Text] [Related]
15. Chimeric and humanized anti-HM1.24 antibodies mediate antibody-dependent cellular cytotoxicity against lung cancer cells.
Wang W; Nishioka Y; Ozaki S; Jalili A; Verma VK; Hanibuchi M; Abe S; Minakuchi K; Matsumoto T; Sone S
Lung Cancer; 2009 Jan; 63(1):23-31. PubMed ID: 18524412
[TBL] [Abstract][Full Text] [Related]
16. Stability of plasmid and expression of a recombinant gonadotropin-releasing hormone (GnRH) vaccine in Escherichia coli.
Xu J; Li W; Wu J; Zhang Y; Zhu Z; Liu J; Hu Z
Appl Microbiol Biotechnol; 2006 Dec; 73(4):780-8. PubMed ID: 16896597
[TBL] [Abstract][Full Text] [Related]
17. GnRH analogs reduce invasiveness of human breast cancer cells.
von Alten J; Fister S; Schulz H; Viereck V; Frosch KH; Emons G; Gründker C
Breast Cancer Res Treat; 2006 Nov; 100(1):13-21. PubMed ID: 16758121
[TBL] [Abstract][Full Text] [Related]
18. [The efficacy of autocatalytic casapse-3 driven by human telomerase reverse transcriptase promoter on human ovarian carcinoma].
Song Y; Shen K; Yu JR
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(41):2919-24. PubMed ID: 18261307
[TBL] [Abstract][Full Text] [Related]
19. [MDR-reversing effect of short peptide binding specifically to multidrug-resistant gastric cancer cells].
Wang P; Ding J; Lin T; Han S; Cao SS; Ge FL; An GQ; Li R; Lei T; Bai FH; Fan DM
Zhonghua Zhong Liu Za Zhi; 2007 Apr; 29(4):258-61. PubMed ID: 17760250
[TBL] [Abstract][Full Text] [Related]
20. Chimeric GnRH-LH receptors and LH receptors lacking C-terminus palmitoylation sites do not localize to plasma membrane rafts.
Lei Y; Hagen GM; Smith SM; Barisas BG; Roess DA
Biochem Biophys Res Commun; 2005 Nov; 337(2):430-4. PubMed ID: 16202972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
